Study To Examine Use of Snake Venom Peptide for MI Treatment

Posted on July 9th, 2012 by

Researchers at the Mayo Clinic’s Cardiorenal Research Laboratory were awarded a $2.5 million grant from the National Heart, Lung, and Blood Institute to study the effects of cenderitide, a designer peptide derived from the venom of the green mamba snake, on the preservation of cardiac and renal function after an MI or acute decompensated HF.

Additional coverage: Wall Street Journal (News Release)

 

Cardiology Today

Tags: Cardiology, Cardiorenal Research Laboratory, cenderitide, National Heart Lung and Blood Institute, Research

You must be logged-in to the site to post a comment.

Contact Us · Privacy Policy